Vaginal pharmacology, including less than 13 mg of dehydropiandrosterona, dehydropiandrosterona sulfate, androst-5-en-3 beta, 17 beta diol or 4android-3, 17 Diona and a precursor; kit; for menopausal symptoms such as urinary incontinence, myocardial infarction, vaginal thirst, imbalance and sexual dysfunction.

摘要

A method for treating and / or reduce the likelihood of acquiring the symptoms or Diseases due to menopause in postmenopausal womenThat involves the use of a sex steroid precursor selected from a defined Group, and Pharmaceutical composition comprising the precursor of Sex steroids.